Northwest Biotherapeutics reported $-13.41M in EBITDA for its fiscal quarter ending in September of 2023.





Ebitda Change Date
Agenus USD -10.11M 19.02M Mar/2025
AstraZeneca USD 5.67B 1.29B Mar/2026
Bristol-Myers Squibb USD 2.88B 1.36B Dec/2025
Celldex Therapeutics USD -83.58M 2.76M Mar/2026
Eisai JPY -335M 30.43B Mar/2026
Infinity Pharmaceuticals USD -10.01M 1.39M Jun/2023
Merck USD 6.3B 2.09B Dec/2025
Northwest Biotherapeutics USD -13.41M 232K Sep/2023
Pfizer USD 5.99B 5.23B Mar/2026
Plus Therapeutics USD -4.4M 2.94M Sep/2025
Roche Holding CHF 12.68B 2.36B Jun/2024